These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Malignant evolution of Schnitzler's syndrome--chronic urticaria and IgM monoclonal gammopathy: report of a new case and review of the literature. Lim W, Shumak KH, Reis M, Perez-Ordonez B, Sauder D, Fam A, Imrie KR. Leuk Lymphoma; 2002 Jan; 43(1):181-6. PubMed ID: 11908725 [Abstract] [Full Text] [Related]
15. Dramatic response to IL1-RA treatment in longstanding multidrug resistant Schnitzler's syndrome: a case report and literature review. Besada E, Nossent H. Clin Rheumatol; 2010 May; 29(5):567-71. PubMed ID: 20119842 [Abstract] [Full Text] [Related]
18. Successful use of anakinra to treat refractory Schnitzler's syndrome. Dybowski F, Sepp N, Bergerhausen HJ, Braun J. Clin Exp Rheumatol; 2008 May; 26(2):354-7. PubMed ID: 18565263 [Abstract] [Full Text] [Related]
19. Urticarial vasculitis associated with a monoclonal IgM gammopathy: Schnitzler's syndrome. Borradori L, Rybojad M, Puissant A, Dallot A, Verola O, Morel P. Br J Dermatol; 1990 Jul; 123(1):113-8. PubMed ID: 2117969 [Abstract] [Full Text] [Related]
20. Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment. Kastritis E, Katoulis A, Terpos E, Panayiotides I, Gavriatopoulopu M, Dimopopoulos MA. Clin Lymphoma Myeloma; 2008 Dec; 8(6):359-62. PubMed ID: 19064402 [Abstract] [Full Text] [Related] Page: [Next] [New Search]